Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)

Ivraj Singh Sandhu, Nicholas James Maksim, Eva Alice Amouzougan, Bryce Wilson Gallion, Anthony L.J. Raviele, Aikseng Ooi

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds